lancet

HYDERABAD: Bharat Biotech International Limited (BBIL)’s whole-virion inactivated Covid-19 vaccine candidate Covaxinhas proven to be safe, well-tolerated, and highly immunogenic in children aged 2-18 years in a phase II/III study, the…

A new study published in the Lancet has revealed that AstraZeneca's Covid-19 vaccine, which is being used in India as Covishield, is well tolerated and immunogenic in children aged 6-17 years. "No safety concerns were raised in this…